Stockscreener 앱 받기
90.19
0.69%
0.62
전일 마감가:
$89.57
열려 있는:
$89.63
하루 거래량:
503.89K
Relative Volume:
0.95
시가총액:
$5.22B
수익:
$76.81M
순이익/손실:
$-162.42M
주가수익비율:
-30.16
EPS:
-2.99
순현금흐름:
$-122.49M
1주 성능:
+0.23%
1개월 성능:
+5.34%
6개월 성능:
+37.61%
1년 성능:
+3.41%
1일 변동 폭
$89.22
$91.78
1주일 범위
$87.85
$93.24
52주 변동 폭
$47.86
$96.39
Arcellx Inc Stock (ACLX) Company Profile
명칭
Arcellx Inc
전화
240-327-0603
주소
800 BRIDGE PARKWAY, REDWOOD CITY
ACLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACLX
Arcellx Inc
|
90.19 | 5.18B | 76.81M | -162.42M | -122.49M | -2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | Wolfe Research | Peer Perform |
| 2025-10-16 | 개시 | Stifel | Buy |
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2024-10-08 | 개시 | Redburn Atlantic | Buy |
| 2024-09-03 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-31 | 개시 | Piper Sandler | Overweight |
| 2024-03-07 | 개시 | Morgan Stanley | Overweight |
| 2024-01-04 | 재확인 | Needham | Buy |
| 2023-12-19 | 개시 | Scotiabank | Sector Outperform |
| 2023-10-30 | 개시 | TD Cowen | Outperform |
| 2023-10-17 | 개시 | UBS | Buy |
| 2023-05-18 | 개시 | Truist | Buy |
| 2023-04-14 | 개시 | Robert W. Baird | Outperform |
| 2023-03-14 | 개시 | Stifel | Buy |
| 2023-02-13 | 개시 | H.C. Wainwright | Buy |
| 2022-12-13 | 재개 | BofA Securities | Buy |
| 2022-10-31 | 개시 | Guggenheim | Buy |
| 2022-10-27 | 개시 | Needham | Buy |
| 2022-07-20 | 개시 | Canaccord Genuity | Buy |
| 2022-03-01 | 개시 | BofA Securities | Buy |
| 2022-03-01 | 개시 | SVB Leerink | Outperform |
모두보기
Arcellx Inc 주식(ACLX)의 최신 뉴스
Can Arcellx Inc. stock withstand economic slowdownEarnings Beat & Proven Capital Preservation Methods - newser.com
Arcellx Inc’s Strategic Advantage in Gilead Partnership Drives Buy Rating and $130 Price Target - TipRanks
Risk vs reward if holding onto Arcellx Inc.Weekly Risk Report & Entry Point Confirmation Signals - newser.com
What institutional flow reveals about Arcellx Inc.Watch List & Fast Entry Momentum Alerts - newser.com
Tools to assess Arcellx Inc.’s risk profileWeekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com
How Arcellx Inc. stock performs during Fed tightening cyclesPrice Action & AI Forecasted Entry/Exit Points - newser.com
Is Arcellx Inc. stock a dividend growth opportunityQuarterly Trade Report & AI Driven Stock Movement Reports - newser.com
Why Arcellx Inc. is moving today2025 Price Targets & Daily Market Momentum Tracking - newser.com
Wolfe Research Initiates Coverage of Arcellx (ACLX) with Peer Perform Recommendation - Nasdaq
Arcellx (NASDAQ: ACLX) plans ASH event on Phase 2 iMMagine-1 myeloma trial data - Stock Titan
Arcellx CMO Heery sells $30,600 in ACLX stock By Investing.com - Investing.com South Africa
Arcellx CMO Heery sells $30,600 in ACLX stock - Investing.com
Arcellx stock initiated at Peerperform by Wolfe Research amid BCMA market competition - Investing.com Nigeria
Arcellx initiated with a Peer Perform at Wolfe Research - TipRanks
Can technical indicators confirm Arcellx Inc.’s reversalGlobal Markets & High Return Stock Watch Alerts - newser.com
Will Arcellx Inc. stock split again soonJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
Trend analysis for Arcellx Inc. this weekSwing Trade & Community Trade Idea Sharing - newser.com
Price-Driven Insight from (ACLX) for Rule-Based Strategy - news.stocktradersdaily.com
Using Python tools to backtest Arcellx Inc. strategiesWatch List & Stepwise Entry and Exit Trade Signals - newser.com
Arcellx Inc.: Promising Developments and Strategic Positioning Drive Buy Rating - TipRanks
Arcellx, Inc. Reports Increased Loss Amid Rising Expenses - TipRanks
Arcellx Inc (ACLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):